Evidence map›Paper›PMID 29868588›Full record

ArticleFrontiers in medicine2018

The Quadruple Helix-Based Innovation Model of Reference Sites for Active and Healthy Ageing in Europe: The Ageing@Coimbra Case Study.

João O Malva, Alda Amado, Alexandra Rodrigues, Anabela Mota-Pinto, Ana F Cardoso, Ana M Teixeira, Ana Todo-Bom, António Devesa, António F Ambrósio, António L Cunha and 12 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

João O MalvaAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Alda AmadoAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Alexandra RodriguesAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Anabela Mota-PintoAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Ana F CardosoAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Ana M TeixeiraAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Ana Todo-BomAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
António DevesaAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
António F AmbrósioAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
António L CunhaAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Bárbara GomesAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Carina DantasAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Cidalina AbreuAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Isabel SantanaAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Jean BousquetContre les Maladies Chroniques pour un VIeilissement Active (MACVIA) en France en EIP on AHA Reference Site, Montpellier, France.
João ApóstoloAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Lúcia SantosAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Lúcio Meneses de AlmeidaAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Maddalena IllarioDivision for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
Rafaela VeríssimoCentro Hospitalar de Gaia/Espinho, Gaia, Portugal.
Vitor RodriguesAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.
Manuel T VeríssimoAgeing@Coimbra, EIP on AHA Reference Site, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Challenges posed by demographic changes and population aging are key priorities for the Horizon 2020 Program of the European Commission. Aligned with the vision of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), the development, exchange, and large-scale adoption of innovative good practices is a key element of the responses required to ensure all European citizens remain as active and healthy as possible as they age. Urged by the need of developing scalable disruptive innovation across Europe, the European Commission and the EIP on AHA created the Reference Sites; local coalition of partners that develop good practices to support AHA. Ageing@Coimbra is an example of how this can be achieved at a regional level. The consortium comprises over 70 institutions that develop innovative practices to support AHA in Portugal. Ageing@Coimbra partners support a regional network of stakeholders that build a holistic ecosystem in health and social care, taking into consideration the specificities of the territories, living environments and cultural resources (2,243,934 inhabitants, 530,423 aged 65 or plus live in the Centre Region of Portugal). Good practices in reducing the burden of brain diseases that affect cognition and memory impairment in older people and tackling social isolation in urban and rural areas are among the top priorities of Ageing@Coimbra. Profiting from the collaborative work of academia, business companies, civil society, and authorities, the quadruple helix of Ageing@Coimbra supports: early diagnosis of frailty and disease; care and cure; and active, assisted, and independent living. This paper describes, as a Community Case Study, the creation of a Reference Site of the EIP on AHA, Ageing@Coimbra, and its impact in Portugal. This Reference Site can motivate other regions to develop innovative formulas to federate stakeholders and networks, building consortia at regional level. This growing movement, across Europe, is inspired by the quadruple helix concept and by the replication of innovative good practices; creating new Reference Sites for the benefit of Citizens.

Indexed as

active and healthy agingageing (aging)European commissioninnovationreference sites

Identifiers

PMID29868588
PMCPMC5952223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.